GBA (NM_001005741) Human Recombinant Protein
CAT#: TP761812
Purified recombinant protein of Human glucosidase, beta, acid (GBA), transcript variant 2, full length, with N-terminal GST and C-terminal His tag, expressed in E. coli, 50ug
Specifications
| Product Data | |
| Species | Human |
| Expression Host | E. coli |
| Expression cDNA Clone or AA Sequence |
A DNA sequence encoding human full-length GBA
|
| Tag | N-GST and C-His |
| Predicted MW | 83.5 kDa |
| Concentration | >50 ug/mL as determined by microplate BCA method |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Buffer | 50mM Tris, pH8.0,8M Urea. |
| Storage | Store at -80°C. |
| Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
| Reference Data | |
| RefSeq | NP_001005741 |
| Locus ID | 2629 |
| UniProt ID | P04062, B7Z6S9, A0A068F658 |
| Cytogenetics | 1q22 |
| Refseq Size | 2583 |
| Refseq ORF | 1608 |
| Synonyms | GBA1; GCB; GLUC |
| Summary | 'This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]' |
| Protein Families | Druggable Genome |
| Protein Pathways | Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
Documents
| FAQs |
Resources
Recombinant Protein Resources |
Other Versions
| SKU | Description | Size | Price |
|---|---|---|---|
| LC400055 | GBA HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LC423641 | GBA HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LC423642 | GBA HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
| LC425145 | GBA HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LC433165 | GBA HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LY400055 | Transient overexpression lysate of glucosidase, beta, acid (GBA), transcript variant 1 |
USD 436.00 |
|
| LY423641 | Transient overexpression lysate of glucosidase, beta, acid (GBA), transcript variant 2 |
USD 436.00 |
|
| LY423642 | Transient overexpression lysate of glucosidase, beta, acid (GBA), transcript variant 3 |
USD 665.00 |
|
| LY425145 | Transient overexpression lysate of glucosidase, beta, acid (GBA), transcript variant 3 |
USD 396.00 |
|
| LY433165 | Transient overexpression lysate of glucosidase, beta, acid (GBA), transcript variant 5 |
USD 436.00 |
|
| PH301614 | GBA MS Standard C13 and N15-labeled recombinant protein (NP_001005741) |
USD 2,055.00 |
|
| PH312242 | GBA MS Standard C13 and N15-labeled recombinant protein (NP_001005742) |
USD 2,055.00 |
|
| PH316061 | GBA MS Standard C13 and N15-labeled recombinant protein (NP_000148) |
USD 2,055.00 |
|
| TP301614 | Purified recombinant protein of Homo sapiens glucosidase, beta; acid (includes glucosylceramidase) (GBA), transcript variant 2 |
USD 867.00 |
|
| TP312242 | Purified recombinant protein of Homo sapiens glucosidase, beta; acid (includes glucosylceramidase) (GBA), transcript variant 3 |
USD 748.00 |
|
| TP312293 | Purified recombinant protein of Homo sapiens glucosidase, beta; acid (includes glucosylceramidase) (GBA), transcript variant 5 |
USD 748.00 |
|
| TP316061 | Recombinant protein of human glucosidase, beta; acid (includes glucosylceramidase) (GBA), transcript variant 1 |
USD 748.00 |
{0} Product Review(s)
Be the first one to submit a review
Germany
Japan
United Kingdom
China